Roadmap: publish sequence-qualified viral coding references for cancer RNA and the GDC panel

Aperta
#91 1 commento 0 reazioni 0 assegnatari Vedi su GitHub

I maintainer di solito rispondono entro 1 giorno

Nessuno ha ancora preso questa issue.

Valutazione

Difficoltà
5/5
Tempo stimato
Più di una settimana
Idoneità per principianti
8/100
Tipo di issue
Funzionalità
Chiarezza
Abbastanza chiara
Stato di attività
Attiva
Ambito
data

Direzione di ricerca

This is a tracking roadmap, so start from a child issue rather than this one. The HPV16 seed (#92, shipped in ORFdata 0.29.0) shows the pattern: native SourceRNA and TranscriptORF objects, source-validated RefSeq CDSs, and the offline consumer example. Any new coverage must keep the pinned inventory SHA256 unchanged and match sequence content before transferring annotation.

Scritto dal modello di indicizzazione a partire dal testo della issue.

Descrizione

ORFdata should distribute versioned viral coding references that Isovar can apply to reconstructed sample RNA. This is reference annotation work, building on the existing native RNA/ORF models rather than introducing a viral ORF class hierarchy.

Deliverables

The first release should be the independently qualified HPV16 seed; the broader panel should not delay that small useful release.

Coverage and reference identity

Account for every one of the 200 viral contigs in GDC GRCh38.d1.vd1's published inventory: 189 HPV entries plus CMV, EBV, HBV, two HCV entries, HIV-1/2, KSHV, HTLV-1, Merkel cell polyomavirus and SV40. Report per-reference source accessions/versions, sequence identity, coding-model counts, available versus incomplete annotation, unresolved features and validation status. A contig being listed must not imply that its coding catalogue is complete.

Keep this historical GDC compatibility snapshot separate from explicitly selected, current strain/lineage expansions. Match actual sequence content, including circular rotation and strand when relevant, before transferring annotation. Never update historical checksums or apply new coordinates by virus name alone. The pinned inventory SHA256 used by Isovar is f221e758f47e4784714b4a89198b89536ddacdc905da9c778a6802d3e1e51c56.

Broader cancer coverage must include HDV, which is absent from that inventory. Maintain source-dated cancer-evidence and inclusion-reason metadata independently from sequence availability. IARC's June 2025 assessment classifies HDV and MCPyV as Group 1 and HCMV as Group 2B. NCI's infectious-agent overview supports prioritizing HPV, EBV, KSHV, HBV/HCV and HTLV-1. Do not label all GDC viruses as established human cancer causes or treat HIV-associated immunosuppression as proof that a tumor expresses an HIV target. Consider additional candidate viruses through evidence review, not an unsupported exhaustive-causality claim.

Shared contract and scope

  • Reuse SourceRNA, TranscriptORF.at, catalogue manifests/cache and existing provenance. Keep source RNA/CDS fragments distinct from fully defined transcripts; preserve ordered coding blocks, strand, phase, translation table and start/stop completeness.
  • Provide deterministic, explicitly installed, offline data selection by exact viral reference. Coordinate with #70/#71 without forcing viral inputs through a human/PyEnsembl-only entry point.
  • Reference coding annotation is distinct from reference protein FASTA layers already supported by ViralProteome. RNA support is distinct from direct translation or protein evidence.
  • Preserve unsupported recoding/processing explicitly and link #65/#67; ordinary source-validated CDS imports should ship independently.
  • Isovar owns observed RNA reconstruction, read support and sample-specific protein predictions. It must preserve variation and incomplete coding sequence rather than fill missing bases from reference. Downstream integration: openvax/isovar#465.

Acceptance: versioned reference releases, an offline consumer example using native ORFdata objects, qualified real-source fixtures, and a coverage manifest that exposes gaps. Keep the verified HPV16 smoke test available throughout expansion.

Seed release: ORFdata 0.29.0 is published, via #99 (closes #92). It provides nine source-validated RefSeq NC_001526.4 CDSs, qualified against both native and GDC HPV16 DNA. The downstream coding consumer is Isovar PR #516. Remaining family issues retain explicit coverage and unsupported-feature requirements.

Lingua principale
Python
Stelle
1
Fork
1
Merge medio
10h 11m
PR unite (30g)
51

Preparare l'ambiente

Questo progetto non fornisce container di sviluppo, Dockerfile né guida per i contributori, quindi l'ambiente è a tuo carico: parti dal suo README e consulta la nostra guida al primo contributo per i passaggi generali.

Come iniziare

  1. Leggi tutta la issue e poi la guida ai contributi del progetto.
  2. Commenta sulla issue per dire che te ne occupi tu — evita che due persone facciano lo stesso lavoro.
  3. Fai un fork del repository e lavora su un branch.
  4. Apri una pull request che faccia riferimento al numero della issue.

Altre issue di openvax/orfdata

Tutte le issue di openvax/orfdata

Issue simili

Altre issue su Python

Ricevi le nuove issue nella tua casella

Un breve riepilogo di issue GitHub adatte ai principianti.